Angiotensin II receptor blocking 2,3,6 substituted quinazolinone

Details Angiotensin II receptor blocking 2,3,6 substituted quinazolinone Angiotensin II receptor blocking 2,3,6 substituted quinazolinone

1993-04-23

1994-03-08

Bernhardt, Emily

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

5142345, 514259, 544116, 544119, 544284, 544287, 544 92, 540524, 546141, 548542, C07D40114, C07D40314, A61K 31505, A61K 31535

Patent

active

052927342

ABSTRACT:
This disclosure describes novel 2, 3, 6 substituted quinazolinones having the formula: ##STR1## wherein X, R, and R.sup.6 are described in the specification which have activity as angiotensin II (AII) antagonists.

REFERENCES:
patent: 5162325 (1992-11-01), Chakravarty et al.
patent: 5202322 (1993-04-01), Allen et al.
patent: 5204354 (1993-04-01), Chakravarty et al.

Affiliated with

Also associated with

Rating

Angiotensin II receptor blocking 2,3,6 substituted quinazolinone does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Angiotensin II receptor blocking 2,3,6 substituted quinazolinone, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin II receptor blocking 2,3,6 substituted quinazolinone will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-153405